Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
216. |
ECCT/20/11/01 | GC vaccine study in kenya Protocol Title: USE OF BEXSERO IMMUNIZATION TO DETECT CROSS REACTIVE ANTIGENS AND ANTI-GONOCOCCAL ANTIBODIES IN KEY POPULATIONS IN KENYA. |
Principal Investigator(s) 1. Prof. Eduard Sanders Site(s) in Kenya The KEMRI-Wellcome Trust Research Programme (KWTRP) Kenya Medical Research Institute (KEMRI) / Wellcome Trust Centre for Geographic Medicine Research – Coast (CGMRC) |
View |
217. |
ECCT/20/11/03 | IMR-SCD-301 A Phase 2b Study to Evaluate the Safety and Efficacy of IMR-687 in Subjects with Sickle Cell Disease |
Principal Investigator(s) 1. Jessie Nyokabi Githanga 2. Videlis Nduba Site(s) in Kenya 1. Kenya Medical Research Institute-Kondele Children\'s Hospital (Kisumu county) 2. The Center For Respiratory Disease Research/KEMRI (Nairobi City county) 3. Gertrude\'s Children\'s Hospital (Nairobi City county) |
View |
218. |
ECCT/21/06/11 | Pulse oximeter use in labour The use of Fetal Pulse Oximetry in determining fetal wellbeing during labour: A non-randomized clinical trial |
Principal Investigator(s) 1. Felix Mwembi Oindi Site(s) in Kenya Aga Khan University hospital |
View |
219. |
ECCT/20/10/03 | Commercial Typhoid tests valid Comparative study of commercially available typhoid point of care tests to benchmark current and emerging tools |
Principal Investigator(s) 1. Robert Sanaya Onsare Site(s) in Kenya 1. Mbagathi County Hospital (Nairobi City county) 2. Medical Missionaries of Mary, Reuben Centre Hospital, Mukuru (Nairobi City county) 3. City Council Clinic, Mukuru (Nairobi City county) |
View |
220. |
ECCT/20/10/04 | yellow fever vaccine CVIA 079 A Phase III double-blind, randomized, active comparator controlled study in healthy Kenyan adolescents, young children and infants to assess the safety and immunogenicity of Beijing Institute of Biologic Products (BIBP) yellow fever vaccine in comparison to a WHO 17D-204 prequalified comparator yellow fever vaccine, as well as lot-to-lot consistency of immune response to the BIBP yellow fever vaccine”, CVIA 079. |
Principal Investigator(s) 1. Dr. Deborah Langat Site(s) in Kenya KEMRI/KERICHO CLINIC RESEARCH CENTRE |
View |